Publications

1: Tang Y, Chen R, Huang Y, Li G, Huang Y, Chen J, Duan L, Zhu BT, Thrasher JB, Zhang X, Li B. Natural Compound Alternol Induces Oxidative Stress-Dependent Apoptotic Cell Death Preferentially in Prostate Cancer Cells. Mol Cancer Ther. 2014 Mar 31. [Epub ahead of print] PubMed PMID: 24688053.

2: Liu WJ, Luo MN, Tan J, Chen W, Huang LZ, Yang C, Pan Q, Li B, Liu HF. Autophagy activation reduces renal tubular injury induced by urinary proteins. Autophagy. 2014 Feb; 10(2):243-56. doi:0.4161/auto.27004. Epub 2013 Nov 26. PubMed PMID: 24345797.

3: Chen R, Zeng X, Zhang R, Huang J, Kuang X, Yang J, Liu J, Tawfik O, Brantley Thrasher J, Li B. Ca(v)1.3 channel α(1D) protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Urol Oncol. 2013 Sep 17. pii: S1078-1439(13)00243-3. doi: 10.1016/j.urolonc.2013.05.011. [Epub ahead of print] PubMed PMID: 24054868.

4: Yang J, Xie SX, Huang Y, Ling M, Liu J, Ran Y, Wang Y, Thrasher JB, Berkland C, Li B. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. Nanomedicine (Lond). 2012 Sep; 7(9):1297-309. Epub 2012 May 14. PubMed PMID: 22583574; PubMed Central PMCID: PMC3448843.

5: Zhao Y, Duan S, Zeng X, Liu C, Davies NM, Li B, Forrest ML. Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells. Mol Pharm. 2012 Jun 4; 9(6):1705-16. doi: 10.1021/mp3000309. Epub 2012 May 1. PubMed PMID: 22494444; PubMed Central PMCID: PMC3601665.

6: Yao K, Youn H, Gao X, Huang B, Zhou F, Li B, Han H. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. Prostate. 2012 Sep 15; 72(13):1423-30. doi: 10.1002/pros.22493. Epub 2012 Jan 30. PubMed PMID: 22290244.

7: Cai Z, Li B, Li K, Zhao B. Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells. J Alzheimers Dis. 2012; 29(1):89-98. doi: 10.3233/JAD-2012-111649. PubMed PMID: 22214783.

8: Chen P, Yu J, Chalmers B, Drisko J, Yang J, Li B, Chen Q. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs. 2012 Apr; 23(4):437-44. doi:10.1097/CAD.0b013e32834fd01f. PubMed PMID: 22205155.

9: Tai W, Shukla RS, Qin B, Li B, Cheng K. Development of a peptide-drug conjugate for prostate cancer therapy. Mol Pharm. 2011 Jun 6; 8(3):901-12. doi: 10.1021/mp200007b. Epub 2011 May 3. PubMed PMID: 21510670; PubMed Central PMCID: PMC3163154.

10: Zhu Q, Yang J, Han S, Liu J, Holzbeierlein J, Thrasher JB, Li B. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo. Prostate. 2011 Jun 1; 71(8):835-45. doi: 10.1002/pros.21300. Epub 2010 Oct 28. PubMed PMID: 21456066.

11: Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells. Prostate. 2011 Sep; 71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9. PubMed PMID: 21308712; PubMed Central PMCID: PMC3143312.

12: Li C, Ford ES, Li B, Giles WH, Liu S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 2010 Jul; 33(7):1618-24. doi: 10.2337/dc09-1788. Epub 2010 Apr 5. PubMed PMID: 20368409; PubMed Central PMCID: PMC2890370.

13: Yang J, Takahashi Y, Cheng E, Liu J, Terranova PF, Zhao B, Thrasher JB, Wang HG, Li B. GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J Cell Sci. 2010 Mar 15; 123(Pt 6):861-70. doi:10.1242/jcs.060475. Epub 2010 Feb 16. PubMed PMID: 20159967; PubMed Central PMCID: PMC2831760.

14: Sun A, Tang J, Terranova PF, Zhang X, Thrasher JB, Li B. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study. Int J Cancer. 2010 Feb 1; 126(3):764-74. doi:10.1002/ijc.24778. PubMed PMID: 19642108.

15: Li H, Ruan G, Li Z, Liu Z, Zheng X, Zheng H, Cheng G, Li B, Zhan M. The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells. J Exp Clin Cancer Res. 2009 Jul 14; 28:100. doi: 10.1186/1756-9966-28-100. PubMed PMID:  19602280; PubMed Central PMCID: PMC2716307.

16: Yang J, Li B. HSP70 silencing combined with AIF: a novel therapeutic approach for cancer. Cancer Biol Ther. 2009 May; 8(9):799-800. Epub 2009 May 2. PubMed PMID: 19333011.

17: Saleem M, Murtaza I, Tarapore RS, Suh Y, Adhami VM, Johnson JJ, Siddiqui IA, Khan N, Asim M, Hafeez BB, Shekhani MT, Li B, Mukhtar H. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis. 2009 May; 30(5):808-17. doi: 10.1093/carcin/bgp044. Epub 2009 Feb 20. PubMed PMID: 19233958; PubMed Central PMCID: PMC2722146.

18: Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, Luo J, Christenson L, Li B, Zhang J, Jackson PD, Faber P, Brunden KR, Harrington JJ, Quarles LD. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One. 2008; 3(12):e3858. doi: 10.1371/journal.pone.0003858. Epub 2008 Dec 3. PubMed PMID: 19050760; PubMed Central PMCID: PMC2585477.

19: Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Prostate. 2008 Mar 1; 68(4):453-61. doi: 10.1002/pros.20723. PubMed PMID: 18196538.

20: Sun A, Shanmugam I, Song J, Terranova PF, Thrasher JB, Li B. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Prostate. 2007 Jun 15; 67(9):976-88. PubMed PMID: 17440966.

21: Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate. 2007 Feb 1; 67(2):203-13. PubMed PMID: 17075831.

22: Li B, Sun A, Youn H, Hong Y, Terranova PF, Thrasher JB, Xu P, Spencer D. Conditional Akt activation promotes androgen-independent progression of prostate cancer. Carcinogenesis. 2007 Mar; 28(3):572-83. Epub 2006 Oct 10. PubMed PMID: 17032658.

23: Chen L, Meng S, Wang H, Bali P, Bai W, Li B, Atadja P, Bhalla KN, Wu J. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824. Mol Cancer Ther. 2005 Sep; 4(9):1311-9. PubMed PMID: 16170022.

24: Liao X, Tang S, Thrasher JB, Griebling TL, Li B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther. 2005 Apr; 4(4):505-15. PubMed PMID: 15827323.

25: Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology. 2004 Jun; 145(6):2941-9. Epub 2004 Feb 26. PubMed PMID: 14988390.

26: Liao X, Zhang L, Thrasher JB, Du J, Li B. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther. 2003 Nov;2(11):1215-22. PubMed PMID: 14617795.

27: Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology. 2003 May; 144(5):1656-63. PubMed PMID: 12697668.

Last modified: Jun 02, 2014
ID=x7279